
CDMO News
eXmoor Pharma Secures MIA(IMP) License from MHRA
eXmoor Pharma has reached a key milestone by obtaining a Manufacturing and Import Authorization for Investigational Medicinal Products (MIA(IMP)) license from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). This authorization permits the company to produce good manufacturing practice